The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Open accessAbstract
BACKGROUND & AIMS: Diagnostic criteria for metabolic associated fatty liver disease (MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic accuracy of the MAFLD definition vs the existing NAFLD criteria to identify patients with significant fibrosis and to characterize the impact of mild alcohol intake. METHODS: We enrolled 765 Japanese patients with fatty liver (median age 54 years). MAFLD and NAFLD were diagnosed in 79.6% and 70.7% of patients respectively. Significant fibrosis was defined by FIB-4 index ≥1.3 and liver stiffness ≥6.6 kPa using shear wave elastography. Mild alcohol intake was defined as <20 g/day. Factors associated with significant fibrosis were analysed by logistic regression and decision-tree analyses. RESULTS: Liver stiffness was higher in MAFLD compared to NAFLD (7.7 vs 6.8 kPa, P = .0010). In logistic regression, MAFLD (OR 4.401; 95% CI 2.144-10.629; P < .0001), alcohol intake (OR 1.761; 95% CI 1.081-2.853; P = .0234), and NAFLD (OR 1.721; 95%CI 1.009-2.951; P = .0463) were independently associated with significant fibrosis. By decision-tree analysis, MAFLD, but not NAFLD or alcohol consumption was the initial classifier for significant fibrosis. The sensitivity for detecting significant fibrosis was higher for MAFLD than NAFLD (93.9% vs 73.0%). In patients with MAFLD, even mild alcohol intake was associated with an increase in the prevalence of significant fibrosis (25.0% vs 15.5%; P = .0181). CONCLUSIONS: The MAFLD definition better identifies a group with fatty liver and significant fibrosis evaluated by non-invasive tests. Moreover, in patients with MAFLD, even mild alcohol consumption is associated with worsening of hepatic fibrosis measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic-associated fatty liver disease (MAFLD), is the most common finding in patients with TS.717”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [717]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationSterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · cited 4×
“ALT (U/L) 19 (14-29) 4-122 22 (16-33) 4-188 .”
InfluentialMach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
Griswold, M. G., Fullman, N., Hawley, C., Arian, N., Zimsen, S. R. M., Tymeson, H. D., Venkateswaran, V., Tapp, A. D., Forouzanfar, M. H., Salama, J. S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31310-2 · Cited by 3,524
Cited by
Sorted by citations
Items 301–400 of 401
Yu, C., Chen, L., Hu, W., Lei, X., Liu, X.-L., Xu, Z.-X., Chen, C., & Zhao, H. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03762-w · Cited by 3
Steatotic liver disease: what role does alcohol consumption play?
Testino, G., Fucile, C., Gnocchi, M., Rosa, G. M., & Caputo, F. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09726-5 · Cited by 3
Cao, W., Xu, Y., Shen, Y., Wang, Y., Ma, X., & Bao, Y. (2022) · Annals of Nutrition and Metabolism · doi:10.1159/000526075 · Cited by 3
Méndez‐Sánchez, N., Fan, J., El‐Kassas, M., & Girala, M. (2022) · Liver International · doi:10.1111/liv.15422 · Cited by 3
Keitoku, T., Tamaki, N., Kurosaki, M., Inada, K., Kirino, S., Uchihara, N., Suzuki, K., Tanaka, Y., Miyamoto, H., Ishido, S., et al. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13805 · Cited by 3
Xin, Z., Huang, J., Cao, Q., Wang, J., He, R., Hou, T., Ding, Y., Lu, J., Wang, T., Zhao, Z., et al. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00734-3 · Cited by 2
Kakisaka, K., Kuroda, H., Abe, T., Nakaya, I., Watanabe, T., Yusa, K., Sato, H., Suzuki, A., Kooka, Y., Endo, K., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13928 · Cited by 3
Extracellular Vesicles and Fatty Liver
Lu, X., Song, M., & Gao, N. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_9 · Cited by 3
Uojima, H., Sakaguchi, Y. M., Gotoh, K., Satoh, T., Hidaka, H., Take, A., Horio, K., Hayashi, S., & Kusano, C. (2023) · Digestive Diseases · doi:10.1159/000534284 · Cited by 3
Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action
Fernandez, C. J., Nagendra, L., & Pappachan, J. M. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.20.1.1 · Cited by 3
Song, B. G., Kang, T. W., Sinn, D. H., Kim, Y., Min, J. H., Hwang, J. A., & Shin, J. (2024) · Clinical Imaging · doi:10.1016/j.clinimag.2024.110097 · Cited by 3
Sogabe, M., Okahisa, T., Kagawa, M., Kashihara, T., Fujmoto, S., Kawaguchi, T., Yokoyama, R., Kagemoto, K., Tanaka, H., Kida, Y., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14221 · Cited by 3
Liu, Q., Bi, J., Fan, G., Wu, M., Qin, X., Fang, Q., Mei, S., Wan, Z., Lv, Y., Song, L., et al. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127566 · Cited by 3
Hashida, R., Kawaguchi, T., Nakano, D., Tsutsumi, T., Kawaguchi, M., Takahashi, H., Tajima, H., Matsuse, H., Golabi, P., Gerber, L. H., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002895 · Cited by 3
Metabolic dysfunction-associated steatotic liver disease
Chen, C., & Liao, D.-M. (2024) · 童綜合醫學雜誌 · doi:10.4103/etmj.etmj-d-24-00019 · Cited by 3
Targher, G. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.59 · Cited by 3
Gambardella, M. L., & Abenavoli, L. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0754 · Cited by 3
Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study
Wang, Q., Su, Y., Niu, J., Wang, Y., Liu, L., & Hao, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331140 · Cited by 2
Pasqua, L. G. D., Palladini, G., Croce, A. C., Milanesi, G., Cavallo, M., Adorini, L., Ferrigno, A., & Vairetti, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211023 · Cited by 2
Unveiling the prognostic power of FIB-4 index: a new frontier in heart failure mortality
Lu, W., Wang, C., Zhu, H., Zheng, X., Ji, F., Lin, M., Zheng, Y., Lin, K., & Guo, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03616-x · Cited by 2
Toktogulova, N. A. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.4.12 · Cited by 2
Shaikh, S. S., Arisar, F. A. Q., Nafay, S., Zaheer, S., Shaikh, H., & Azam, Z. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i1.54 · Cited by 2
Jafari, E., Merat, S., Anoushiravani, A., Radmard, A. R., Roshandel, G., Sharafkhah, M., Khoshnia, M., Nateghi, A., Khuzani, A. S., Poustchi, H., et al. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.374 · Cited by 2
Cheng, Y., Hsieh, T.-H. J., Wang, C., & Kao, J. (2024) · JGH Open · doi:10.1002/jgh3.70039 · Cited by 2
Xiong, F., Zhang, X., Jiang, Y., Meng, P., Zhou, Y., Ji, X., Chen, J., Wu, T., & Hou, Y. (2024) · Metabolites · doi:10.3390/metabo14120681 · Cited by 2
Lee, Y. R., Woo, H. Y., Kweon, Y. O., Tak, W. Y., Jang, S. Y., Park, J. G., Kang, M. K., Song, J. E., Jang, B. K., Lee, C., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70064 · Cited by 2
Lu, N. L., Lam, H. T., & Vo, T. D. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i37.110797 · Cited by 2
Lee, C. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.01.005 · Cited by 3
Balci, I. C., Hacıağaoğlu, N., Öner, C., Çeti̇n, H., & Şimşek, E. E. (2023) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2023.04.390 · Cited by 2
Ogasawara, Y., Kogiso, T., Horiuchi, K., Taniai, M., & Tokushige, K. (2023) · JGH Open · doi:10.1002/jgh3.12898 · Cited by 2
Anushiravani, A., Rayatpisheh, M., Kasaeian, A., & Oskouie, I. M. (2024) · Archives of Iranian Medicine · doi:10.34172/aim.2024.36 · Cited by 2
Editorial for the Bibliometric-enhanced Information Retrieval Workshop at ECIR 2014
Mayr, P., Schaer, P., Scharnhorst, A., & Mutschke, P. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1404.7099 · Cited by 2
Metabolically Healthy Obese MAFLD: Are They Truly Healthy?
Fouad, Y. M., & Zheng, M. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.010 · Cited by 2
Armandi, A., & Bugianesi, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00022-7 · Cited by 1
Non-alcoholic Fatty Liver Disease
Kim, S. F., & Choi, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_36-2 · Cited by 1
Impact of High-Temperature Feeds on Gut Microbiota and MAFLD
Xue, L., Li, K., Jia, Y., Yao, D., Guo, X., & Zhang, S. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2405.05023 · Cited by 1
Matboli, M., El-Attar, N. E., Abdelbaky, I., Khaled, R., Saad, M., Ghani, A. M. A., Barakat, E., Guirguis, R. N. M., Khairy, E., & Hamady, S. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156882 · Cited by 1
Nawata, H., Ou, L., Zhang, X., Song, Q., Huang, J., Hu, J., Ito, K., Obo, S., Fukushima, T., Iwami, K., et al. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0554 · Cited by 1
Pan, Y., Feng, X., Wang, S., Zhong, B., Zhan, Y., Wang, Q., Xu, Y., Rao, H., Mi, Y., Nan, Y., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1610083 · Cited by 1
Chen, S. J., Xu, D., Hu, D. K., Hu, P. J., & Huang, T. (2025) · JMIR Medical Informatics · doi:10.2196/75747 · Cited by 1
GUPTA, M., Kumar, D., Chandra, K. P., & Maheshwari, A. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01611-w · Cited by 1
Metabolic dysfunction-associated fatty liver disease from definition to complications
Ezzat, A. A., & Elmoghazy, M. (2021) · Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis · doi:10.21608/mjvh.2021.211705 · Cited by 1
Non-alcoholic fatty liver disease and the risk of malignant tumors
Livzan, M. A., Syrovenko, M. I., & Сергеевна, К. Т. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-355 · Cited by 1
Livzan, M. A., Сергеевна, К. Т., & Syrovenko, M. I. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-218-10-168-174 · Cited by 1
The Influence of Price, Halal Brands, and Marketing Management Strategies on Consumer Satisfaction
Rohimah, R. (2024) · Journal of Halal Science Industry and Business · doi:10.31098/jhasib.v2i1.1991 · Cited by 1
Sotoudeheian, M. (2024) · The International Journal of Gastroenterology and Hepatology Diseases · doi:10.2174/0126662906302851240604042954 · Cited by 1
Sonneveld, M. J., Parouei, F., den Hoed, C. M., de Jonge, J., Salarzaei, M., Porte, R. J., Janssen, H. L. A., Rosmalen, M. D. R.-V., Vogelaar, S., van der Meer, A. J., et al. (2024) · Clinical Transplantation · doi:10.1111/ctr.15437 · Cited by 1
Kulikova, M. S., & Eganyan, R. A. (2024) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20242708187 · Cited by 1
Decoding MASLD’s Pathophysiology
Abenavoli, L., & Scarlata, G. G. M. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_3 · Cited by 1
MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
Scheinberg, A. R., & John, B. V. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07512-w · Cited by 1
The MASLD‐MAFLD debate: Another phase of eminence versus evidence
Fouad, Y. M., Abdelhalim, S. M., Said, E., & Abd-Elsalam, S. M. (2024) · Liver International · doi:10.1111/liv.15972 · Cited by 1
Fatty liver disease – A multifaceted disease with more than one name?
Schattenberg, J. M., & Labenz, C. (2020) · Liver International · doi:10.1111/liv.14727
Başaranoğlu, M., & Kurtoglu, A. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001494
Gu, J., Zhao, Y., & Ren, D. (2009) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.185634
Kodama, T., Kozumi, K., & Takehara, T. (2021) · Kanzo · doi:10.2957/kanzo.62.681
陽明学左派の「狂」について--明代後期の思想における「狂」の諸相(2)
八木, 章. (2011) · 慶応義塾大学言語文化研究所紀要
Fujii, H., Fukumoto, S., Enomoto, M., Uchida‐Kobayashi, S., Kimura, T., Tamori, A., Nadatani, Y., Takashima, S., Nishimoto, N., & Kawada, N. (2021) · Research Square · doi:10.21203/rs.3.rs-148501/v1
Sumida, Y. (2022) · Hepatology Research · doi:10.1111/hepr.13762
Wang, S., Wang, P., Zhang, Q., Luo, T., & Qin, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1965788/v1
Mosaad, A. M., Elalfy, H., Amer, T., & Arafa, M. (2022) · Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis · doi:10.21608/mjvh.2022.258088
A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in ChinaPreprint
Liu, Q., Zhao, G., Li, Q., Wu, W., Zhang, Y., & Bian, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1713068/v2
New Concept of Fatty Liver: Metabolic dysfunction-associated fatty liver disease
Kawaguchi, T. (2023) · Kanzo · doi:10.2957/kanzo.64.33
A Cross-Sectional Study on Association between Metabolic Syndrome and Hepatobiliary Cancers
Shehzad, M. I., Haq, A. U., Zada, I., Shahid, M. A., Qureshi, N. K., & Azeem, S. B. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023171339
Jung, H. N., & Jung, C. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0038
Chatterjee, A., Mondal, B., Das, K., Mondal, D., Ghosh, R., Chowdhury, A., & Basu, P. (2023) · medRxiv · doi:10.1101/2023.05.11.23289665
Diagnostic Criteria of Dual Diagnosis Fatty Liver Disease is Better for Fatty Liver ResearchPreprint
Cheng, Y., Hsieh, T.-H. J., Wang, C., & Kao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3018239/v1
Nawata, H., Ou, L., Zhang, X., Song, Q., Huang, J., Hu, J., Ito, K., Obo, S., Fukushima, T., Iwami, K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2987345/v1
Vysochanska, V. V. (2023) · Перспективи та інновації науки · doi:10.52058/2786-4952-2023-13(31)-685-706
Mykhalchyshyn, G., Kobyliak, N. M., Komisarenko, I., & Yerokhovych, V. (2023) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/usmyj.3(141).2023.88-96
Zhang, W., Huang, J., Li, H., & Meng, Q. (2023) · Research Square · doi:10.21203/rs.3.rs-3397501/v1
Ciaula, A. D., & Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03448-9
Juárez‐Fernández, M. (2023) · Buleria (Universidad de León) · doi:10.18002/10612/17419
Imai, J., Takashimizu, S., Suzuki, N., Ohshinden, K., Sawamoto, K., Mishima, Y., Tsuruya, K., Arase, Y., Yamano, M., Kishimoto, N., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3947258/v1
Lahnsteiner, A., Ellmer, V., Oberlercher, A., Liutkevičiūtė, Z., Schönauer, E., Paulweber, B., Aigner, E. S., & Risch, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.21.585382
Yin, J., Zhang, N., Feng, Y., Meng, Q., Zhang, T., Hong, R., & Zhang, X. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000114
Future directions for fatty liver disease
Bartolomeo, A. D., & George, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00016-9
Kaya, E., & Yilmaz, Y. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00012-1
Yeh, M., Huang, J., & Yu, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00008-x
Selective Modulation of Aryl Hydrocarbon Receptor by Coptisine in MAFLDPreprint
Zhu, X., Liu, Q., Cheng, Z., & Luo, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5201468/v1
Pan, Z., & Eslam, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_13
Méndez‐Sánchez, N., Ramírez-Mejía, M. M., & Eslam, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_1
Hong, S., Hong, Z.-F., Hao, Y., Sun, L., & Wei, H. (2025) · Medicine · doi:10.1097/md.0000000000041455 · Cited by 1
She, C., Guo, Z., Lin, Y., Zhou, S., Pang, M., Liu, J., Cao, L., Su, L., Sun, Y., Fang, C., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101639
Kamada, Y., Sumida, Y., Takahashi, H., Fujii, H., Kawanaka, M., Nakajima, A., & Forum, J. (2025) · Kanzo · doi:10.2957/kanzo.66.105
Chen, S. J., Xu, D., Hu, D. K., Hu, P. J., & Huang, T. (2025) · doi:10.2196/preprints.75747
Chen, Y., Lai, Y., Ou, S., Xie, Y., & Cheng, Q. (2025) · Research Square · doi:10.21203/rs.3.rs-7048643/v1
Metabolic dysfunction-associated steatotic liver disease in metabolic syndrome
Drapkina, O. M., & Nedogoda, S. V. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6541 · Cited by 2
Xin, Z., Huang, J., Cao, Q., Wang, J., He, R., Hou, T., Ding, Y., Lu, J., Wang, T., Zhao, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574271
Feng, Z., Zhao, F., Wang, Z., Tang, X., Xie, Y., & Qiu, L. (2024) · Figshare · doi:10.6084/m9.figshare.25422329
Li, D., Cai, H., Guohua, L., Han, Y., Qiu, K., Liu, W., Meng, K., & Yang, P. (2024) · Figshare · doi:10.6084/m9.figshare.26682427
Xie, X., Guo, B., Xiao, X., Yin, J., Wang, Z., Jiang, X., Li, J., Long, L., Zhou, J., Zhang, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18585831
Li, D., Cai, H., Guohua, L., Han, Y., Qiu, K., Liu, W., Meng, K., & Yang, P. (2024) · Figshare · doi:10.6084/m9.figshare.26682421
Li, D., Cai, H., Guohua, L., Han, Y., Qiu, K., Liu, W., Meng, K., & Yang, P. (2024) · Figshare · doi:10.6084/m9.figshare.26682418
Li, D., Cai, H., Guohua, L., Han, Y., Qiu, K., Liu, W., Meng, K., & Yang, P. (2024) · Figshare · doi:10.6084/m9.figshare.26682424
Eldaba, A. M., Watany, M. M., Elkassas, G., & sheshtawy, R. B. E. (2026) · Tanta Medical Journal · doi:10.4103/tmj.tmj_8_25
Jeyaraj, F. T., Vennam, S. S., Nelson, K. L., Watts, K., Goss, L. R., Nance, B., Mass, B. B., & Voruganti, V. S. (2026) · Food & Function · doi:10.1039/d5fo03248b
Wen, Y., Amjad, N., Mukamab, O., Amissah, O. B., Xie, W., Zhou, P., Song, A., Wang, L., Li, J., Huang, R., et al. (2026) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00780-3
Wang, S. H., Chang, Y., Cheng, Y., & Wang, C. C. (2026) · Advances in digestive medicine · doi:10.1002/aid2.70017
Arifin, M., Jannah, W., Zakiyah, N., Meiliana, A., Barliana, M. I., & Lestari, K. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/1644860 · Cited by 1
Integrative Functional Nutrition in Metabolic-Associated Fatty Liver Disease
Güveli, H. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016113
Metadata
- Authors
- Yamamura, S., Eslam, M., Kawaguchi, T., Tsutsumi, T., Nakano, D., Yoshinaga, S., Takahashi, H., Anzai, K., George, J., & Torimura, T.
- Affiliations
- Kurume University (JP)
- The University of Sydney (AU)
- Medical Examination Section Medical Examination Part Facilities Public Utility Foundation Saga Prefectural Health Promotion Foundation Saga Japan
- Saga University (JP)
- Corresponding author
- Yamamura, Sakura
- Eslam, Mohammed
- ORCID
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2020-11-30
- Volume
- 40
- Issue
- 12
- Pages
- 3018-3030
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W3089758949
- Cited by
- 401
- References
- 38
- Citations by year
- 2026: 10 · 2025: 33 · 2024: 85 · 2023: 96 · 2022: 84 · 2021: 84 · 2020: 6
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- Liver International (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- Japan Agency for Medical Research and Development (JP20fk0210040)
- Research and Development
- Medical Foundation (APP1107178, APP1108422)
- University of Sydney
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- metabolic-associated fatty liver disease, non-alcoholic fatty liver disease, liver fibrosis, diagnostic accuracy, liver stiffness, shear wave elastography, FIB-4, hepatic steatosis, noninvasive fibrosis assessment
- MeSH terms
- Humans, Liver Cirrhosis, Middle Aged, Prevalence, Logistic Models, Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
